These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6206141)

  • 1. Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process.
    Bowen DL; Fauci AS
    J Immunol; 1984 Oct; 133(4):1885-90. PubMed ID: 6206141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I.
    Kehrl JH; Muraguchi A; Fauci AS
    Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
    Muraguchi A; Kehrl JH; Butler JL; Fauci AS
    J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
    Kehrl JH; Muraguchi A; Fauci AS
    J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation.
    Cupps TR; Gerrard TL; Falkoff RJ; Whalen G; Fauci AS
    J Clin Invest; 1985 Feb; 75(2):754-61. PubMed ID: 3871795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
    Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
    J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human B cell activation: selective sensitivity of the early stages to calcium channel-blocking drugs.
    Dugas B; Vazquez A; Delfraissy JF; Gérard JP; Rannou MT; Galanaud P
    Eur J Immunol; 1986 Feb; 16(2):162-7. PubMed ID: 2420605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diacetyl diamines on in vitro activation and proliferation of human B lymphocytes.
    Lacy J; Summers WC; Canellakis ZN
    J Immunol; 1985 Dec; 135(6):3772-6. PubMed ID: 3877754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor.
    Richard Y; Leprince C; Dugas B; Treton D; Galanaud P
    J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
    Suzuki T; Butler JL; Cooper MD
    J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140.
    Pezzutto A; Dörken B; Moldenhauer G; Clark EA
    J Immunol; 1987 Jan; 138(1):98-103. PubMed ID: 3097151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective suppression of an early step in human B cell activation by cyclosporin A.
    Muraguchi A; Butler JL; Kehrl JH; Falkoff RJ; Fauci AS
    J Exp Med; 1983 Sep; 158(3):690-702. PubMed ID: 6193229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody.
    Mond JJ; Finkelman FD; Sarma C; Ohara J; Serrate S
    J Immunol; 1985 Oct; 135(4):2513-7. PubMed ID: 3928753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
    Defrance T; Aubry JP; Vanbervliet B; Banchereau J
    J Immunol; 1986 Dec; 137(12):3861-7. PubMed ID: 3097134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta.
    Petit-Koskas E; Génot E; Lawrence D; Kolb JP
    Eur J Immunol; 1988 Jan; 18(1):111-6. PubMed ID: 3257917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional properties of two human B cell growth factor species separated by lectin affinity column.
    Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P
    J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.
    Tedder TF; Boyd AW; Freedman AS; Nadler LM; Schlossman SF
    J Immunol; 1985 Aug; 135(2):973-9. PubMed ID: 3925015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.